CARLE CANCER CENTER COMMUNITY CLINICAL ONCOLOGY PROGRAM

卡尔癌症中心社区临床肿瘤学项目

• 批准号: 2088870
• 负责人: ALAN K HATFIELD
• 金额: $ 24.35万
• 依托单位: CARLE FOUNDATION
• 依托单位国家: 美国
• 财政年份: 1990
• 资助国家: 美国
• 起止时间: 1990-06-01 至 1998-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/2088870
• 关键词: breast neoplasm /cancer diagnosis; breast neoplasms; cancer prevention; cancer rehabilitation /care; clinical trials; community health services; cooperative study; female; human subject; human therapy evaluation; neoplasm /cancer chemotherapy; neoplasm /cancer diagnosis; neoplasm /cancer education; neoplasm /cancer therapy

In response to RFA CA-92-15 Community Clinical Oncology Program, National Cancer Institute, the Carle Cancer Center CCOP, Urbana, Illinois, is making application to continue to be designated as a CCOP in East Central Illinois. As the 12th largest private medical group practice in the United States, with over 250 physicians, the Carle Clinic Association has a fully developed community cancer center program which has been involved in national clinical trials research since 1976. Joining Carle in this CCOP application as a component institution will be the Suburban Heights Medical Center of Chicago Heights, Illinois, a physician group practice of more than 60 physicians. Also joining Carle as affiliate institutions are the Carbondale Clinic, Carbondale, Illinois, a 35 physician group practice located in southern Illinois, and a private physician group practice in Joliet, Illinois. The combined Carle Cancer Center CCOP provides services to cancer patients from a large, nearly contiguous catchment area covering areas of east central, northeast and southern Illinois. The headquarters for the CCOP will be located at the Carle Cancer Center with all randomization, administrative matters and quality assurance programs being based there. The CCOPs primary research base is the North Central Cancer Treatment group (NCCTG), headquartered at the Mayo Clinic. Other research base affiliations will be with the Eastern Cooperative Oncology Group (ECOG) and the National Surgical Adjuvant Breast and Bowel Project (NSABP). The Illinois Cancer Center (ICC) has been a research base but will lose funding effective 12/92. CCOP dedicated research staff personnel and nurse clinicians will assist the investigating physicians in placing patients on clinical cancer research protocols resulting in 155 cancer treatment credits and 230 cancer control credits annually. One hundred and eighty cancer control credits will come from the Breast Cancer Prevention Trial (NSABP Protocol P-1). The goal of the Carle Cancer Center CCOP is to facilitate transfer of modern methods of cancer treatment, control and prevention to the citizens and health professionals of the proposed service area. It is the Carle Cancer Center CCOPs continued belief that a community cancer center program should maintain participation in clinical research protocols, public and professional education and cancer prevention and detection as well as providing the highest standards of clinical cancer care.

响应RFA CA-92-15社区临床肿瘤学计划，国家 伊利诺伊州厄巴纳的卡勒癌症中心癌症研究所，是 申请继续被指定为中环东区的CCOP 伊利诺伊州。作为全球第12大私人医疗集团 美国，拥有250多名医生，Carle诊所协会 一个全面发展的社区癌症中心项目，已经参与其中 自1976年起参与国家临床试验研究。加入Carle的行列 CCOP申请作为一个组成部分的机构将是郊区高地 伊利诺伊州芝加哥高地医疗中心，医生团体执业 60多名内科医生。还作为附属机构加入Carle 是伊利诺伊州卡本代尔的卡本代尔诊所，一个35人的医生团体 位于伊利诺伊州南部的Practice和一个私人医生团体 在伊利诺伊州乔利埃特实习。联合Carle癌症中心CCOP 为癌症患者提供服务从大型的，几乎连续的 集水区覆盖东部、中部、东北部和南部地区 伊利诺伊州。 CCOP的总部将设在Carle癌症中心 随机化、行政化、质保化 以那里为基地的项目。CCOPS的主要研究基地是北方 中心癌症治疗小组(NCCTG)，总部设在梅奥诊所。 其他研究基地的附属机构将与东方合作社 肿瘤学小组(ECOG)和国家外科辅助乳肠 项目(NSABP)。伊利诺伊州癌症中心(ICC)进行了一项研究 基础，但将失去12/92生效的资金。CCOP专职研究 工作人员和护士临床医生将协助调查 医生在为患者安排临床癌症研究方案方面的作用 导致155个癌症治疗学分和230个癌症控制学分 每年一次。180个癌症控制学分将来自 乳腺癌预防试验(NSABP P-1议定书)。 Carle癌症中心CCOP的目标是促进 现代癌症治疗、控制和预防方法 拟议服务区的公民和卫生专业人员。它是 Carle癌症中心CCOPS坚持认为，社区癌症 中心计划应保持对临床研究的参与 方案、公共和专业教育以及癌症预防和治疗 检测以及提供最高标准的临床癌症 关心。